Views & Analysis
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Surprise pandemic lessons for pharma
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Oncology, IQVIA, Oncology, pandemic, SARS
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Lessons from the first generation of cell and gene oncology trials
mike.hammerton@pharmaphorum.com
Brandon Fletcher, Deep Dive, Deep Dive: Oncology, gene therapies, ICON, Oncology, Tamie Joeckel
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Oncology R&D: the patient insights we’re still missing, and how to catch up
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Oncology, Oncology, patient engagement, Prime Global, R&D
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Digital tools key to immuno-oncology’s future: report
mike.hammerton@pharmaphorum.com
asco, BrightInsight, Deep Dive, Deep Dive: Oncology, digital health, Oncology
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Oncology and a year of COVID: lessons for the future
mike.hammerton@pharmaphorum.com
covid, Deep Dive, Deep Dive: Oncology, Frances O’Connor, Lucid, Lucid Group, Oncology, pandemic
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
How hybrid virtual engagement is accelerating oncology communication
mike.hammerton@pharmaphorum.com
communication, covid, Deep Dive, Deep Dive: Oncology, Mike Abbadessa, Natalie DiMambro, Oncology, Sarah Diffen, Within3
0 Comment
Deep Dive/ Oncology/ Views & Analysis/ Views and analysis
Enabling healthcare’s digital future
mike.hammerton@pharmaphorum.com
Debiopharm Innovation, Deep Dive, Deep Dive: Oncology, digital health, Oncology, start ups
0 Comment
Oncology/ Views & Analysis/ Views and analysis
What HCPs think about health equity in cancer care
mike.hammerton@pharmaphorum.com
cancer, Oncology, What HCPs Think
0 Comment